These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16106403

  • 1. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
    Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S, Kataoka H.
    Int J Cancer; 2006 Feb 01; 118(3):583-92. PubMed ID: 16106403
    [Abstract] [Full Text] [Related]

  • 2. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 3. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C, Jiang WG.
    Int J Oncol; 2001 Oct 01; 19(4):857-63. PubMed ID: 11562767
    [Abstract] [Full Text] [Related]

  • 4. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
    Phin S, Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malanda C, Kataoka H, Soler P, Crestani B.
    Am J Respir Cell Mol Biol; 2010 Mar 01; 42(3):286-93. PubMed ID: 19448157
    [Abstract] [Full Text] [Related]

  • 5. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 6. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).
    Kataoka H, Itoh H, Hamasuna R, Meng JY, Koono M.
    Hum Cell; 2001 Mar 15; 14(1):83-93. PubMed ID: 11436357
    [Abstract] [Full Text] [Related]

  • 7. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC, Fan S, Walter KA, Abounader R, Williams JA, Rosen EM, Laterra J.
    Cancer Res; 2000 Aug 01; 60(15):4277-83. PubMed ID: 10945642
    [Abstract] [Full Text] [Related]

  • 8. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
    Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Woude GF.
    Cancer Res; 1997 Dec 01; 57(23):5391-8. PubMed ID: 9393765
    [Abstract] [Full Text] [Related]

  • 9. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J.
    J Natl Cancer Inst; 1999 Sep 15; 91(18):1548-56. PubMed ID: 10491431
    [Abstract] [Full Text] [Related]

  • 10. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
    Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Merchant M, Schwall R, Westphal M, Lamszus K.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6144-52. PubMed ID: 17062691
    [Abstract] [Full Text] [Related]

  • 11. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 15; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor (HGF) system in gingiva: HGF activator expression by gingival epithelial cells.
    Ohshima M, Sakai A, Sawamoto Y, Seki K, Ito K, Otsuka K.
    J Oral Sci; 2002 Dec 15; 44(3-4):129-34. PubMed ID: 12613501
    [Abstract] [Full Text] [Related]

  • 13. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells.
    Hamasuna R, Kataoka H, Meng JY, Itoh H, Moriyama T, Wakisaka S, Koono M.
    Int J Cancer; 2001 Aug 01; 93(3):339-45. PubMed ID: 11433397
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract.
    Matsubara Y, Ichinose M, Yahagi N, Tsukada S, Oka M, Miki K, Kimura S, Omata M, Shiokawa K, Kitamura N, Kaneko Y, Fukamachi H.
    Biochem Biophys Res Commun; 1998 Dec 18; 253(2):477-84. PubMed ID: 9878561
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
    Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G, Yoshino S.
    J Rheumatol; 2001 Aug 18; 28(8):1772-8. PubMed ID: 11508578
    [Abstract] [Full Text] [Related]

  • 16. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):645-61. PubMed ID: 21464397
    [Abstract] [Full Text] [Related]

  • 17. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M.
    Int J Cancer; 1999 Jul 19; 82(2):274-81. PubMed ID: 10389763
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4578-85. PubMed ID: 14555533
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.
    Int J Cancer; 2010 Oct 15; 127(8):1948-57. PubMed ID: 20104519
    [Abstract] [Full Text] [Related]

  • 20. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S, Fukushima T, Naka D, Tanaka H, Osada Y, Kataoka H.
    FEBS J; 2008 Mar 15; 275(5):1003-17. PubMed ID: 18221492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.